Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.
Financial Results:
Abbott India Ltd reported Revenues for Q4FY25 of ₹6,375.00 Crores up from ₹4,707.00 Crore year on year, a rise of 35.44%.
Total Expenses for Q4FY25 of ₹5,623.00 Crores up from ₹4,359.00 Crores year on year, a rise of 29.0%.
Consolidated Net Profit of ₹714.00 Crores up 87.4% from ₹381.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.39, up 66.36% from ₹3.24 in the same quarter of the previous year.